Barbareschi M - Search Results

1

Role of circulating tumor DNA in the detection of sensitizing and resistance to epidermal growth factor receptor mutations in metastatic lung adenocarcinoma.

Veccia A, Girlando S, Dipasquale M, Kinspergher S, Barbareschi M, Caffo O. Veccia A, et al. Among authors: barbareschi m. J BUON. 2020 Mar-Apr;25(2):848-854. J BUON. 2020. PMID: 32521877 Free article.

2

PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.

Leonardi E, Girlando S, Serio G, Mauri FA, Perrone G, Scampini S, Dalla Palma P, Barbareschi M. Leonardi E, et al. Among authors: barbareschi m. J Clin Pathol. 1992 May;45(5):416-9. doi: 10.1136/jcp.45.5.416. J Clin Pathol. 1992. PMID: 1350788 Free PMC article.

3

Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms.

Barbareschi M, Girlando S, Mauri FA, Arrigoni G, Laurino L, Dalla Palma P, Doglioni C. Barbareschi M, et al. J Pathol. 1992 Apr;166(4):343-50. doi: 10.1002/path.1711660405. J Pathol. 1992. PMID: 1355531

4

p53 protein expression in basal cell carcinomas.

Barbareschi M, Girlando S, Cristofolini P, Cristofolini M, Togni R, Boi S. Barbareschi M, et al. Histopathology. 1992 Dec;21(6):579-81. doi: 10.1111/j.1365-2559.1992.tb00449.x. Histopathology. 1992. PMID: 1468757 No abstract available.

5

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.

Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F. Gasparini G, et al. Among authors: barbareschi m. J Clin Oncol. 1994 Mar;12(3):454-66. doi: 10.1200/JCO.1994.12.3.454. J Clin Oncol. 1994. PMID: 7509851

6

Expression of mdm-2 and p53 protein in transitional cell carcinoma.

Barbareschi M, Girlando S, Fellin G, Graffer U, Luciani L, Dalla Palma P. Barbareschi M, et al. Urol Res. 1995;22(6):349-52. doi: 10.1007/BF00296873. Urol Res. 1995. PMID: 7537927

7

Invasive node-negative breast carcinoma: multivariate analysis of the prognostic value of peritumoral vessel invasion compared with that of conventional clinico-pathologic features.

Barbareschi M, Dalla Palma P, Bevilacqua P, Maluta S, Caffo O, Meli S, Boracchi P, Gasparini G. Barbareschi M, et al. Anticancer Res. 1994 Sep-Oct;14(5B):2229-35. Anticancer Res. 1994. PMID: 7840528

8

mdm2 gene alterations and mdm2 protein expression in breast carcinomas.

Marchetti A, Buttitta F, Girlando S, Dalla Palma P, Pellegrini S, Fina P, Doglioni C, Bevilacqua G, Barbareschi M. Marchetti A, et al. Among authors: barbareschi m. J Pathol. 1995 Jan;175(1):31-8. doi: 10.1002/path.1711750106. J Pathol. 1995. PMID: 7891224

9

Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas.

Barbareschi M, Girlando S, Mauri FM, Forti S, Eccher C, Mauri FA, Togni R, Dalla Palma P, Doglioni C. Barbareschi M, et al. Am J Clin Pathol. 1994 Aug;102(2):171-5. doi: 10.1093/ajcp/102.2.171. Am J Clin Pathol. 1994. PMID: 8042584

10

p53 Protein expression in nevi and melanomas.

Cristofolini M, Boi S, Girlando S, Zumiani G, Cristofolini P, Dalla Palma P, Doglioni C, Barbareschi M. Cristofolini M, et al. Among authors: barbareschi m. Arch Dermatol. 1993 Jun;129(6):739-43. Arch Dermatol. 1993. PMID: 8507076

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page